BRISTOL-MYERS SQUIBB COMPANY Operating Cash Flow
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Operating Cash Flow of $4.50 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $3.39B, a 13.38% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $1.10B, a 43.50% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $1.97B, a 55.53% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $6.31B, a 12.88% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for fiscal 2025 was $14.16B, a 6.81% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for fiscal 2024 was $15.19B, a 9.60% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for fiscal 2023 was $13.86B, a 6.08% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY net cash provided by (used in) operating activities for fiscal 2022 was $13.07B, a 19.38% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.39B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.50B 10-Q · filed 2026-07-30 | $6.47B derived: sum of 3 quarters · filed 2026-07-30 | $12.78B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $1.10B 10-Q · filed 2026-04-30 | $3.08B derived: sum of 2 quarters · filed 2026-04-30 | $9.39B derived: sum of 3 quarters · filed 2026-04-30 | $13.31B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $8.29B derived: sum of 2 quarters · filed 2026-02-11 | $12.20B derived: sum of 3 quarters · filed 2026-07-30 | $14.16B 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $6.31B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.23B derived: sum of 2 quarters · filed 2026-07-30 | $12.18B 10-Q · filed 2025-10-30 | $16.62B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $3.92B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $5.87B 10-Q · filed 2026-07-30 | $10.31B derived: sum of 3 quarters · filed 2026-07-30 | $15.90B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $1.95B 10-Q · filed 2026-04-30 | $6.39B derived: sum of 2 quarters · filed 2026-04-30 | $11.98B derived: sum of 3 quarters · filed 2026-04-30 | $14.31B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $4.44B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $10.03B derived: sum of 2 quarters · filed 2026-02-11 | $12.36B derived: sum of 3 quarters · filed 2026-02-11 | $15.19B 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | $5.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $7.92B derived: sum of 2 quarters · filed 2025-10-30 | $10.75B 10-Q · filed 2025-10-30 | $15.00B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $2.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $5.16B 10-Q · filed 2025-07-31 | $9.41B derived: sum of 3 quarters · filed 2026-02-11 | $14.16B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $2.83B 10-Q · filed 2025-04-24 | $7.09B derived: sum of 2 quarters · filed 2026-02-11 | $11.84B derived: sum of 3 quarters · filed 2026-02-11 | $13.72B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $4.25B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $9.00B derived: sum of 2 quarters · filed 2026-02-11 | $10.89B derived: sum of 3 quarters · filed 2026-02-11 | $13.86B 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | $4.75B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $6.64B derived: sum of 2 quarters · filed 2024-10-31 | $9.61B 10-Q · filed 2024-10-31 | $12.91B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $1.89B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $4.86B 10-Q · filed 2024-07-26 | $8.16B derived: sum of 3 quarters · filed 2025-02-12 | $11.85B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $2.97B 10-Q · filed 2024-04-25 | $6.28B derived: sum of 2 quarters · filed 2025-02-12 | $9.96B derived: sum of 3 quarters · filed 2025-02-12 | $12.22B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $3.31B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $6.99B derived: sum of 2 quarters · filed 2025-02-12 | $9.25B derived: sum of 3 quarters · filed 2025-02-12 | $13.07B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $3.69B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $5.95B derived: sum of 2 quarters · filed 2023-10-26 | $9.76B 10-Q · filed 2023-10-26 | $13.82B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $2.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $6.07B 10-Q · filed 2023-07-27 | $10.13B derived: sum of 3 quarters · filed 2024-02-13 | $15.40B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $3.81B 10-Q · filed 2023-04-27 | $7.87B derived: sum of 2 quarters · filed 2024-02-13 | $13.13B derived: sum of 3 quarters · filed 2024-02-13 | $16.20B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $4.06B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $9.32B derived: sum of 2 quarters · filed 2024-02-13 | $12.38B derived: sum of 3 quarters · filed 2024-02-13 | $16.21B 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $5.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $8.33B derived: sum of 2 quarters · filed 2022-10-26 | $12.15B 10-Q · filed 2022-10-26 | $15.51B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-06-30 | $3.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $6.88B 10-Q · filed 2022-07-27 | $10.24B derived: sum of 3 quarters · filed 2023-02-14 | $12.51B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-03-31 | $3.82B 10-Q · filed 2022-04-29 | $7.18B derived: sum of 2 quarters · filed 2023-02-14 | $9.45B derived: sum of 3 quarters · filed 2023-02-14 | $13.94B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2020-12-31 | $3.35B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $5.62B derived: sum of 2 quarters · filed 2023-02-14 | $10.12B derived: sum of 3 quarters · filed 2023-02-14 | $14.05B 10-K · filed 2023-02-14 | ||||
| 2020-09-30 | $2.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $6.76B derived: sum of 2 quarters · filed 2021-10-27 | $10.70B 10-Q · filed 2021-10-27 | $10.38B 10-Q · filed 2020-11-05 | $12.88B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $4.49B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $8.43B 10-Q · filed 2021-07-28 | $8.16B 10-Q · filed 2020-08-06 | $10.61B derived: sum of 3 quarters · filed 2022-02-09 | $13.17B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $3.94B 10-Q · filed 2021-04-29 | $3.89B 10-Q · filed 2020-05-07 | $6.12B derived: sum of 2 quarters · filed 2022-02-09 | $8.67B derived: sum of 3 quarters · filed 2022-02-09 | $10.76B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $2.18B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $4.74B derived: sum of 2 quarters · filed 2022-02-09 | $6.82B derived: sum of 3 quarters · filed 2022-02-09 | $8.21B 10-K · filed 2022-02-09 | $8.07B 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $2.56B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.64B derived: sum of 2 quarters · filed 2020-11-05 | $6.03B 10-Q · filed 2020-11-05 | $9.58B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-06-30 | $2.08B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.47B 10-Q · filed 2020-08-06 | $7.03B derived: sum of 3 quarters · filed 2021-02-10 | $8.31B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-03-31 | $1.39B 10-Q · filed 2020-05-07 | $4.95B derived: sum of 2 quarters · filed 2021-02-10 | $6.22B derived: sum of 3 quarters · filed 2021-02-10 | $7.28B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2018-12-31 | $3.56B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $4.83B derived: sum of 2 quarters · filed 2021-02-10 | $5.89B derived: sum of 3 quarters · filed 2021-02-10 | $7.07B 10-K · filed 2021-02-10 | $5.94B 10-K · filed 2019-02-25 | |||
| 2018-09-30 | $1.28B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.34B derived: sum of 2 quarters · filed 2019-10-31 | $3.51B 10-Q · filed 2019-10-31 | $4.63B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $2.23B 10-Q · filed 2019-07-25 | $3.35B derived: sum of 3 quarters · filed 2020-02-24 | $5.06B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $1.18B 10-Q · filed 2019-04-25 | $2.29B derived: sum of 2 quarters · filed 2020-02-24 | $4.00B derived: sum of 3 quarters · filed 2020-02-24 | $5.59B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $2.83B derived: sum of 2 quarters · filed 2020-02-24 | $4.41B derived: sum of 3 quarters · filed 2020-02-24 | $5.28B 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $1.71B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $3.30B derived: sum of 2 quarters · filed 2018-10-25 | $4.16B 10-Q · filed 2018-10-25 | $5.60B derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $1.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $2.44B 10-Q · filed 2018-07-26 | $3.89B derived: sum of 3 quarters · filed 2019-02-25 | $5.29B derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $861.00M 10-Q · filed 2018-04-26 | $2.30B derived: sum of 2 quarters · filed 2019-02-25 | $3.71B derived: sum of 3 quarters · filed 2019-02-25 | $4.15B derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $2.85B derived: sum of 2 quarters · filed 2019-02-25 | $3.29B derived: sum of 3 quarters · filed 2019-02-25 | $3.06B 10-K · filed 2019-02-25 | $2.85B 10-K · filed 2017-02-21 | |||
| 2016-09-30 | $1.40B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $1.84B derived: sum of 2 quarters · filed 2017-10-26 | $1.61B 10-Q · filed 2017-10-26 | $1.42B 10-Q · filed 2016-10-27 | $2.50B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $439.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $211.00M 10-Q · filed 2017-07-27 | $25.00M 10-Q · filed 2016-07-28 | $1.09B derived: sum of 3 quarters · filed 2018-02-13 | $1.62B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | -$228.00M 10-Q · filed 2017-04-27 | -$386.00M 10-Q · filed 2016-04-28 | $656.00M derived: sum of 2 quarters · filed 2018-02-13 | $1.18B derived: sum of 3 quarters · filed 2018-02-13 | $1.25B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $884.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.41B derived: sum of 2 quarters · filed 2018-02-13 | $1.48B derived: sum of 3 quarters · filed 2018-02-13 | $2.10B 10-K · filed 2018-02-13 | $1.83B 10-K · filed 2016-02-12 | |||
| 2015-09-30 | $524.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $595.00M derived: sum of 2 quarters · filed 2016-10-27 | $1.22B 10-Q · filed 2016-10-27 | $1.79B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $697.00M 10-Q · filed 2016-07-28 | $1.27B derived: sum of 3 quarters · filed 2017-02-21 | $2.17B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $626.00M 10-Q · filed 2016-04-28 | $1.20B derived: sum of 2 quarters · filed 2017-02-21 | $2.10B derived: sum of 3 quarters · filed 2017-02-21 | $3.16B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $572.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $1.48B derived: sum of 2 quarters · filed 2017-02-21 | $2.53B derived: sum of 3 quarters · filed 2017-02-21 | $3.15B 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $903.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $1.96B derived: sum of 2 quarters · filed 2015-10-27 | $2.58B 10-Q · filed 2015-10-27 | $3.99B derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $1.67B 10-Q · filed 2015-07-23 | $3.08B derived: sum of 3 quarters · filed 2016-02-12 | $4.14B derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | $617.00M 10-Q · filed 2015-04-28 | $2.03B derived: sum of 2 quarters · filed 2016-02-12 | $3.08B derived: sum of 3 quarters · filed 2016-02-12 | $4.59B derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $2.46B derived: sum of 2 quarters · filed 2016-02-12 | $3.97B derived: sum of 3 quarters · filed 2016-02-12 | $3.54B 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | $1.05B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $2.56B derived: sum of 2 quarters · filed 2014-10-24 | $2.13B 10-Q · filed 2014-10-24 | $2.97B derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $1.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $1.08B 10-Q · filed 2014-07-24 | $1.92B derived: sum of 3 quarters · filed 2015-02-13 | $6.50B derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | -$428.00M 10-Q · filed 2014-04-29 | $408.00M derived: sum of 2 quarters · filed 2015-02-13 | $4.99B derived: sum of 3 quarters · filed 2015-02-13 | $6.13B derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $836.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $5.42B derived: sum of 2 quarters · filed 2015-02-13 | $6.55B derived: sum of 3 quarters · filed 2015-02-13 | $6.94B 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $4.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $5.72B derived: sum of 2 quarters · filed 2013-10-23 | $6.11B 10-Q · filed 2013-10-23 | $7.67B derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-06-30 | $1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $1.52B 10-Q · filed 2013-07-25 | $3.09B derived: sum of 3 quarters · filed 2014-02-14 | $4.79B derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-03-31 | $387.00M 10-Q · filed 2013-04-25 | $1.96B derived: sum of 2 quarters · filed 2014-02-14 | $3.65B derived: sum of 3 quarters · filed 2014-02-14 | $4.75B derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2011-12-31 | $1.57B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $3.27B derived: sum of 2 quarters · filed 2014-02-14 | $4.36B derived: sum of 3 quarters · filed 2014-02-14 | $4.84B 10-K · filed 2014-02-14 | ||||
| 2011-09-30 | $1.70B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $2.79B derived: sum of 2 quarters · filed 2012-10-24 | $3.27B 10-Q · filed 2012-10-24 | $4.87B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $1.09B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $1.57B 10-Q · filed 2012-07-25 | $3.17B derived: sum of 3 quarters · filed 2013-02-15 | $4.55B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $481.00M 10-Q · filed 2012-04-26 | $2.08B derived: sum of 2 quarters · filed 2013-02-15 | $3.46B derived: sum of 3 quarters · filed 2013-02-15 | $4.51B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | $1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $2.98B derived: sum of 2 quarters · filed 2013-02-15 | $4.03B derived: sum of 3 quarters · filed 2013-02-15 | $4.49B 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $1.38B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $2.43B derived: sum of 2 quarters · filed 2011-10-27 | $2.90B 10-Q · filed 2011-10-27 | $4.24B derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-06-30 | $1.05B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $1.51B 10-Q · filed 2011-07-28 | $2.86B derived: sum of 3 quarters · filed 2012-02-17 | $4.33B derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-03-31 | $464.00M 10-Q · filed 2011-04-28 | $1.81B derived: sum of 2 quarters · filed 2012-02-17 | $3.28B derived: sum of 3 quarters · filed 2012-02-17 | $4.08B derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2009-12-31 | $1.34B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.82B derived: sum of 2 quarters · filed 2012-02-17 | $3.61B derived: sum of 3 quarters · filed 2012-02-17 | $4.07B 10-K · filed 2012-02-17 | ||||
| 2009-09-30 | $1.47B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $2.27B derived: sum of 2 quarters · filed 2010-10-26 | $2.72B 10-Q · filed 2010-10-26 | $3.12B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-06-30 | $796.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | $1.25B 10-Q · filed 2010-07-22 | $1.64B derived: sum of 3 quarters · filed 2011-02-18 | $3.07B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $452.00M 10-Q · filed 2010-04-29 | $848.00M derived: sum of 2 quarters · filed 2011-02-18 | $2.27B derived: sum of 3 quarters · filed 2011-02-18 | |||||
| 2008-12-31 | $396.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $1.82B derived: sum of 2 quarters · filed 2011-02-18 | $3.71B 10-K · filed 2011-02-18 | |||||
| 2008-09-30 | $1.42B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $3.31B 10-Q · filed 2009-10-22 | ||||||
| 2008-06-30 | $1.89B 10-Q · filed 2009-07-23 | |||||||
| 2007-12-31 | $3.15B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |